Tumors have evolved several strategies to evade immune detection and destruction by helper T cells. These include:
Creating an immunosuppressive microenvironment that inhibits the activity of helper T cells. Downregulating antigen presentation to avoid detection. Expressing immune checkpoint molecules like PD-L1 that inhibit T cell function.
